Key Financial Inc’s Structure Therapeutics GPCR Stock Holding History

Key Financial Inc’s Portfolio GPCR Stock Details GPCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.37K	Hold	100	–	–	﹤0.01%	1008
2026 Q1	$4.82K	Buy	+100	New	+$6.84K	﹤0.01%	1039

Other funds holding GPCR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Jupiter Topco New York $245B AUM

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Key Financial Inc's GPCR Position: Q2 2026 in Review

Key Financial Inc held its Structure Therapeutics (GPCR) position steady in Q2 2026 at 100 shares worth $5.37K. The position accounts for ﹤0.01% of the portfolio, ranked #1008.

Key Financial Inc first reported a position in GPCR in Q1 2026 and has held it in 2 quarters since. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

Key Financial Inc held 100 shares of Structure Therapeutics worth $5.37K as of Q2 2026.
Key Financial Inc left its Structure Therapeutics share count unchanged in Q2 2026.
Structure Therapeutics made up ﹤0.01% of Key Financial Inc's portfolio in Q2 2026, its #1008 holding.
Key Financial Inc first reported a position in Structure Therapeutics in Q1 2026 and has held it in 2 quarters since.
191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Key Financial Inc's 13F filing for Q2 2026, filed 24 Jul 2026.